Ex-Roche chairman Franz Humer committed the parent company to sustaining Genentech’s “innovative culture,” and his successor, Severin Schwan, has stated that he intends to “keep the two respective research and early development organizations as independent units”; merging the two R&D units he says, “would kill innovation” at Genentech. Schwan needs suggestions on how best to follow through on both Humer’s commitment and his own. It is no surprise that your boss has asked you to furnish her with two or three ideas that she might pass on to the CEO. What will your suggestions be?